Morphine Extended-Release Capsules and Sarilumab Subcutaneous
Determining the interaction of Morphine Extended-Release Capsules and Sarilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
Generic Name: sarilumab
Brand name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Morphine Extended-Release Capsules-Sarna Hc Topical application
- Morphine Extended-Release Capsules-Sarnol-HC
- Morphine Extended-Release Capsules-Sarnol-HC Maximum Strength
- Morphine Extended-Release Capsules-SAStid
- Morphine Extended-Release Capsules-Sastid Soap Topical
- Morphine Extended-Release Capsules-SAStid Topical
- Sarilumab Subcutaneous-Morphine Immediate-Release Tablets and Capsules
- Sarilumab Subcutaneous-Morphine injection
- Sarilumab Subcutaneous-Morphine Injection PF
- Sarilumab Subcutaneous-Morphine Long-Acting Tablets
- Sarilumab Subcutaneous-Morphine Oral Concentrate (20 mg/mL)
- Sarilumab Subcutaneous-Morphine Oral Solution